期刊文献+

SEA基因与GPI信号肽序列融合基因的真核表达载体的构建和序列分析 被引量:3

Construction of mammalian cell expression vector of a chimeric SEA-hPLAP-1 cDNA and analysis of its sequence
下载PDF
导出
摘要 目的 将超抗原金黄色葡萄球菌肠毒素A (staphylococcusenterotoxinA ,SEA)基因与人胎盘碱性磷酸酶(hPLAP 1 )C末端信号肽序列 ,即糖基化磷脂酰肌醇 (glycosyl phosphatidylinositol,GPI)附着信号序列 ,拼接成融合基因 ,并构建该融合基因的真核表达载体。方法 利用基因SOEing法 ,分别扩增hPLAP 1C末端信号肽序列和SEA基因 ,然后将二段基因拼接起来 ,拼接后与pGEM T克隆载体连接 ,再亚克隆到真核表达载体pcDNA3 .1 (+)中 ,测序鉴定。结果 分别成功扩增出hPLAP 1C末端信号肽序列 1 31bp和SEA基因 789bp ,并将二段基因序列成功拼接 (90 1bp) ,且成功构建了真核表达载体pcDNA3 .1 (+) /SEA GPI,经测序是正确的。结论 真核表达载体pcDNA3 .1 (+) /SEA GPI的构建 ,为研究SEA GPI抗肿瘤作用奠定了基础。 Objective To construct mammalian cell expression vector of a chimeric SEA hPLAP 1 cDNA. Methods The sea gene and a DNA fragment encoding the signal for GPI anchor attachment of hPLAP 1 were amplified by PCR. The two amplified gene sequence were annealed to form a chimeric GPI anchored SEA molecule by gene SOEing. The resulting chimera was cloned in pGEM T vector and then sub cloned in pcDNA3.1(+) and verified by sequencing analysis. Results The recombinant mammalian cell expression vector of a chimeric SEA hPLAP 1 cDNA〔pcDNA3.1(+)/SEA GPI〕 was successfully constructed ,the sequence was identical to the designed sequence. Conclusion The recombinant mammalian cell expression vector (pcDNA3.1(+)/SEA GPI) of a chimeric SEA hPLAP 1 cDNA could be successfully constructed ,and the plasmid pcDNA3.1(+)/SEA GPI may foundation for further study of the tumor suppression of SEA GPI.
出处 《免疫学杂志》 CAS CSCD 北大核心 2002年第5期343-346,共4页 Immunological Journal
基金 浙江省自然科学基金资助项目 (30 1 580和 3991 31 )
  • 相关文献

参考文献2

二级参考文献2

共引文献11

同被引文献17

  • 1司少艳,隋延仿,胡沛臻,张秀敏,葛伟,李增山,黄杨.肝癌靶向性SEA-CD80基因共表达重组腺病毒载体的构建及表达鉴定[J].细胞与分子免疫学杂志,2006,22(5):613-616. 被引量:8
  • 2Irimura T, Denda K, Iida Si, et al. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity [J]. J Biochem (Tokyo), 1999, 126(6): 975-985.
  • 3Zrihan Licht S, Vos HL, Baruch A, et al. Characterization and molecularcloning of a novel MUC1 protein, devoid of tandem repeats, expressed in human breast cancer tissue [J].Eur J Biochem, 1994, 224(2): 787-795.
  • 4Baruch A, Hartmann M, Zrihan Licht S, et al. Preferential expression of novel MUG1 tumor antigen isoforms in human epithelial tumors and their tumor-potentiating function [J].Int J Cancer, 1997, 71(5): 741-749.
  • 5Irimura T, Denda K, Iida Si, et al. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity [J]. J Biochem (Tokyo), 1999, 126(6): 975-985.
  • 6Obermair A, Schmid BC, Packer LM, et al. Expression of MUC1 splice variants in benign and malignant ovarian tumors [J]. Int J Cancer, 2002, 100(2): 166-171.
  • 7Croce MV, Rabassa ME, PriceMR, et al. MUC1 mucinand carbohydrate associated antigens as tumor markers in head and neck squamous cell carcinoma [J]. Pathol Oncol Res, 2001,7(4): 284-291.
  • 8Buisine MP, Devisme L, Degand P, et al. Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. I. Stomach. A relationship to gastric carcinoma [J]. J Histochem Cytochem, 2000, 48 (12):1657-1666.
  • 9Pecher G, Spahn G, Schirrmann T, et al. Mucin gene (MUC1) transfer into human dendritic cells by cationic liposomes and recombinant adenovirus [J]. Anticancer Res,2001, 21(4A): 2 591-2 596.
  • 10Rughetti A, Biffoni M, Sabbatucci M, et al. Transfected human dendritic cells to induce antituraor immunity [J].Gene Ther, 2000, 7(17): 1 458-1 466.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部